[Oral administration of beraprost sodium did not exacerbate pulmonary hypertension with CREST syndrome]

Nihon Naika Gakkai Zasshi. 2001 May 10;90(5):881-3. doi: 10.2169/naika.90.881.
[Article in Japanese]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • CREST Syndrome / complications*
  • Disease Progression
  • Epoprostenol / analogs & derivatives
  • Epoprostenol / therapeutic use*
  • Female
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Vasodilator Agents / therapeutic use*

Substances

  • Platelet Aggregation Inhibitors
  • Vasodilator Agents
  • beraprost
  • Epoprostenol